查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1551555

行動心電遙測系統的全球市場

Mobile Cardiac Telemetry Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 378 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球行動心電遙測系統市場預計將達到 16 億美元

行動心電遙測系統的全球市場預計到 2023 年將達到 9.767 億美元，預計到 2030 年將達到 16 億美元，在 2023-2030 年分析期間複合年成長率為 6.9%。心絞痛適應症是本報告分析的細分市場之一，預計複合年成長率為 8.6%，到分析期結束時將達到 5.627 億美元。在分析期間，冠狀動脈疾病適應症細分市場的複合年成長率預計為 6.8%。

美國市場預估價值2.661億美元，中國預期複合年成長率為11.3%

預計 2023 年美國行動心電遙測系統市場規模將達 2.661 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達3.475億美元，2023-2030年分析期間複合年成長率為11.3%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 2.9% 和 6.9%。在歐洲，德國的複合年成長率預計為 4.4%。

全球行動心電遙測系統市場 - 主要趨勢與促進因素總結

什麼是移動心電遙測系統？

移動心臟遙測 (MCT) 系統是心臟監測領域的重要進步，可即時連續觀察患者的心臟活動。與傳統的心電圖監測在有限的時間內記錄資料並要求患者返回診所進行資料分析不同，MCT 系統透過行動網路將心電圖資料直接傳輸給醫療保健提供者。這樣可以在發生心律不整或其他心臟事件時立即檢測和介入。 MCT 系統的一個關鍵需求是能夠提供及時、準確和可操作的資料，特別是對於高風險患者和標準檢查室評估可能無法捕獲的短暫性心臟病。這項技術對於診斷心房顫動、心室心搏過速和其他心律不整等疾病尤其重要，如果不及時識別和治療，這些疾病可能會導致嚴重甚至致命的後果。此外，MCT 系統重量輕、穿戴式且侵入性較小，提高了患者的依從性和舒適度，使患者能夠不間斷地進行日常活動。

科技如何提高 MCT 系統的有效性？

行動心電遙測系統背後的技術是先進生物感測器、行動連線和雲端基礎的分析的複雜結合。 MCT 機器通常包括捕捉心臟電活動的電極、將這些資料即時發送到中央監測站的發送器以及分析異常資訊的軟體。人工智慧（AI）和機器學習演算法的整合進一步提高了MCT系統的有效性。這些演算法可以快速識別不規則的心率模式，為醫療保健提供者提供早期警報系統。此外，隨著時間的推移儲存和分析大型資料集的能力可以識別趨勢和模式，從而實現更明智的臨床決策並改善患者的治療結果。現代行動網路的資料傳輸可靠性和低延遲確保即使是最輕微的心臟功能偏差也能被檢測到並快速傳達給醫療專業人員。

消費行為在 MCT 系統的實施中扮演什麼角色？

消費行為和患者參與在行動心電遙測系統的廣泛採用中發揮越來越重要的作用。隨著患者更主動地了解自己的健康狀況，對提供便利、準確且安心的監測解決方案的需求不斷增加。 COVID-19 大流行加速了遠端醫療和遠距醫療保健服務的轉變，進一步凸顯了 MCT 等技術的重要性。患者現在熟悉穿戴式設備，並期望將即時健康監測作為其整體護理策略的一部分。此外，MCT 系統的易用性和非侵入性吸引了更廣泛的人群，包括不喜歡傳統監測方法的老年患者。 MCT 系統的吸引力還在於它與智慧型手機和其他個人裝置的無縫整合。患者可以輕鬆追蹤自己的健康指標並與醫療保健提供者共用資料，從而獲得更個人化的護理。

推動MCT市場成長的因素有哪些？

行動心臟遙測市場的成長是由反映醫療保健和技術發展的幾個因素所推動的。主要促進因素之一是全世界心血管疾病的盛行率不斷上升，特別是在老化人口中，心律不整和其他心臟疾病的風險更高。此外，與心臟病密切相關的文明病（例如肥胖、糖尿病和高血壓）的日益流行，也推動了對 MCT 等連續監測解決方案的需求。行動技術的進步，包括 4G 和 5G 網路的擴展，也透過實現更快、更可靠的資料傳輸發揮關鍵作用，這對於 MCT 系統的即時功能至關重要。此外，對預防性醫療保健和早期診斷的日益關注正在推動醫療保健提供者和患者採用 MCT 系統作為心臟護理的標準部分。多個地區的監管支持和有利的報銷政策進一步支持市場成長，使 MCT 系統可供更廣泛的患者群體使用。最後，隨著市場上更複雜和易於使用的設備的開拓，新用戶不斷湧現，行動心電遙測系統的市場預計將在未來幾年擴大。

受訪企業範例（共42例）

  • ACS Diagnostics, Inc.
  • Baxter International Inc.
  • BioTelemetry, Inc.
  • Biotricity Inc.
  • Boston Scientific Cardiac Diagnostics Inc.
  • Comarch SA
  • GE HealthCare
  • Infinium Medical, Inc.
  • iRhythm Technologies, Inc.
  • LifeSignals, Inc.
  • Medtronic PLC
  • Philips Healthcare USA
  • ScottCare Cardiovascular Solutions
  • Telerhythmics, LLC
  • Zoll Medical Corporation

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP26697

Global Mobile Cardiac Telemetry Systems Market to Reach US$1.6 Billion by 2030

The global market for Mobile Cardiac Telemetry Systems estimated at US$976.7 Million in the year 2023, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2023-2030. Angina Pectoris Indication, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$562.7 Million by the end of the analysis period. Growth in the Coronary Artery Diseases Indication segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$266.1 Million While China is Forecast to Grow at 11.3% CAGR

The Mobile Cardiac Telemetry Systems market in the U.S. is estimated at US$266.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$347.5 Million by the year 2030 trailing a CAGR of 11.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 6.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Mobile Cardiac Telemetry Systems Market - Key Trends and Drivers Summarized

What Are Mobile Cardiac Telemetry Systems and Why Are They Critical?

Mobile Cardiac Telemetry (MCT) systems represent a significant advancement in cardiac monitoring, providing real-time, continuous observation of a patient's heart activity. Unlike traditional Holter monitors, which record data for a limited period and require the patient to return to the clinic for data analysis, MCT systems transmit ECG data directly to healthcare providers via mobile networks. This allows for immediate detection and intervention in cases of arrhythmias or other cardiac events. The critical need for MCT systems lies in their ability to provide timely, accurate, and actionable data, especially for high-risk patients or those experiencing transient cardiac symptoms that might not be captured during a standard in-office evaluation. This technology is particularly crucial for diagnosing conditions like atrial fibrillation, ventricular tachycardia, and other arrhythmias, which can have serious or fatal outcomes if not promptly identified and treated. Additionally, MCT systems enhance patient compliance and comfort, as they are lightweight, wearable, and minimally invasive, enabling patients to go about their daily activities without interruption.

How Does Technology Elevate The Effectiveness of MCT Systems?

The technology behind Mobile Cardiac Telemetry systems is a sophisticated blend of advanced biosensors, mobile connectivity, and cloud-based analytics. MCT devices typically include electrodes that capture the heart's electrical activity, a transmitter that sends this data in real-time to a central monitoring station, and software that analyzes the information for any abnormalities. The integration of artificial intelligence (AI) and machine learning algorithms has further elevated the effectiveness of MCT systems. These algorithms can quickly identify irregular patterns in heartbeats, providing an early warning system for healthcare providers. Furthermore, the ability to store and analyze large datasets over time allows for better patient outcomes, as trends and patterns can be identified, leading to more informed clinical decisions. The reliability of data transmission and the low latency of modern mobile networks ensure that even the slightest deviation in heart function is detected and communicated to medical professionals promptly.

What Role Does Consumer Behavior Play in The Adoption of MCT Systems?

Consumer behavior and patient engagement are playing increasingly vital roles in the widespread adoption of Mobile Cardiac Telemetry systems. As patients become more informed and proactive about their health, there is a growing demand for monitoring solutions that offer convenience, accuracy, and peace of mind. The shift toward telemedicine and remote healthcare services, accelerated by the COVID-19 pandemic, has further highlighted the importance of technologies like MCT. Patients are now more comfortable with wearable devices and expect real-time health monitoring as part of their overall care strategy. Additionally, the ease of use and non-invasive nature of MCT systems appeal to a broader demographic, including elderly patients who might be averse to traditional monitoring methods. The ability of these systems to integrate seamlessly with smartphones and other personal devices also contributes to their appeal, as patients can easily track their own health metrics and share data with their healthcare providers, leading to more personalized care.

What Factors Are Driving The Growth of The MCT Market?

The growth in the Mobile Cardiac Telemetry market is driven by several factors that reflect the evolving landscape of healthcare and technology. One of the primary drivers is the increasing prevalence of cardiovascular diseases globally, particularly in aging populations where the risk of arrhythmias and other heart conditions is higher. Additionally, the rising incidence of lifestyle-related conditions, such as obesity, diabetes, and hypertension, which are closely linked to heart disease, has amplified the need for continuous monitoring solutions like MCT. Advances in mobile technology, including the expansion of 4G and 5G networks, have also played a crucial role by enabling faster and more reliable data transmission, which is essential for the real-time capabilities of MCT systems. Moreover, the growing focus on preventive healthcare and early diagnosis is pushing both healthcare providers and patients toward adopting MCT systems as a standard part of cardiac care. Regulatory support and favorable reimbursement policies in several regions have further bolstered market growth, making these systems more accessible to a wider patient base. Lastly, the ongoing development of more sophisticated and user-friendly devices continues to attract new users, ensuring that the market for Mobile Cardiac Telemetry systems will expand in the coming years.

Select Competitors (Total 42 Featured) -

  • ACS Diagnostics, Inc.
  • Baxter International Inc.
  • BioTelemetry, Inc.
  • Biotricity Inc.
  • Boston Scientific Cardiac Diagnostics Inc.
  • Comarch SA
  • GE HealthCare
  • Infinium Medical, Inc.
  • iRhythm Technologies, Inc.
  • LifeSignals, Inc.
  • Medtronic PLC
  • Philips Healthcare USA
  • ScottCare Cardiovascular Solutions
  • Telerhythmics, LLC
  • Zoll Medical Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Mobile Cardiac Telemetry Systems - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Mobile and Wireless Technologies Propel Growth in Mobile Cardiac Telemetry Systems
    • Rising Incidence of Cardiovascular Diseases Expands Addressable Market Opportunity for MCT
    • Integration of AI and Predictive Analytics Strengthens the Business Case for Real-Time Cardiac Monitoring
    • Increasing Shift Towards Remote Patient Monitoring Drives Adoption of Mobile Cardiac Telemetry
    • Technological Innovations in Wearable Devices Spur Growth in Continuous Heart Monitoring Solutions
    • Growing Awareness of Preventive Healthcare Generates Demand for Early Detection Tools
    • Emerging Markets and Aging Populations Create New Growth Avenues for MCT Systems
    • Challenges in Data Security and Privacy Create Opportunities for Innovation in Secure MCT Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Mobile Cardiac Telemetry Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Mobile Cardiac Telemetry Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Mobile Cardiac Telemetry Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Angina Pectoris by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Angina Pectoris by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Angina Pectoris by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Coronary Artery Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Coronary Artery Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Coronary Artery Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Atherosclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Atherosclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Atherosclerosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Heart Failure & Stroke by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Heart Failure & Stroke by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Heart Failure & Stroke by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Disease Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cardiac Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cardiac Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Cardiac Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Lead-based Telemetry Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Lead-based Telemetry Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Lead-based Telemetry Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Patch-based Telemetry Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Patch-based Telemetry Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Patch-based Telemetry Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • JAPAN
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • CHINA
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • EUROPE
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Mobile Cardiac Telemetry Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Mobile Cardiac Telemetry Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • FRANCE
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • GERMANY
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Spain 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Spain 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Russia 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Russia 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of Europe 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of Europe 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Mobile Cardiac Telemetry Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Mobile Cardiac Telemetry Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Asia-Pacific 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Australia 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Australia 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • INDIA
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: India 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: India 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: South Korea 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: South Korea 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Mobile Cardiac Telemetry Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Mobile Cardiac Telemetry Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Latin America 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 211: Argentina 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 214: Argentina 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 220: Brazil 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 223: Brazil 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 229: Mexico 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 232: Mexico 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 238: Rest of Latin America 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 241: Rest of Latin America 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Mobile Cardiac Telemetry Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Mobile Cardiac Telemetry Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 250: Middle East 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 259: Iran 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 262: Iran 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 268: Israel 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 271: Israel 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 277: Saudi Arabia 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 280: Saudi Arabia 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 286: UAE 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 289: UAE 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 295: Rest of Middle East 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 298: Rest of Middle East 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030
  • AFRICA
    • Mobile Cardiac Telemetry Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Mobile Cardiac Telemetry Systems by Disease Type - Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Mobile Cardiac Telemetry Systems by Disease Type - Percentage Breakdown of Value Sales for Angina Pectoris, Coronary Artery Diseases, Atherosclerosis, Heart Failure & Stroke and Other Disease Types for the Years 2014, 2024 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Mobile Cardiac Telemetry Systems by End-Use - Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 304: Africa 16-Year Perspective for Mobile Cardiac Telemetry Systems by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Cardiac Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Mobile Cardiac Telemetry Systems by System Type - Lead-based Telemetry Systems and Patch-based Telemetry Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 307: Africa 16-Year Perspective for Mobile Cardiac Telemetry Systems by System Type - Percentage Breakdown of Value Sales for Lead-based Telemetry Systems and Patch-based Telemetry Systems for the Years 2014, 2024 & 2030

IV. COMPETITION